BioSupply Trends Quarterly logo
Subscribe
Fall 2012 - Innovation
  Download Issue
Share

Up Front

Publisher's Corner
The Human and Economic Value of Healthcare Innovation
By Patrick M. Schmidt

Features

Myths and Facts: Asthma

Autoimmune Diseases: Exploring Treatment Options

An Update on Meningitis

BioSupply Trends Quarterly Fall 2012 Medical Breakthroughs

Medical Breakthroughs: From Concept to Commercialization

Infusion Environments: Comparing Costs, Safety and Privacy

Blending Alternative and Mainstream Therapies

Companion Diagnostics: The Future of Personalized Medicine

BioTrends Watch

Washington Report
HHS Creates Centers to Safeguard Public
New Law Aims to Accelerate Drug Approvals and Enhance Safety
Revised CMS Rules to Decrease Healthcare Costs
Feds Take Additional Steps to Combat Alzheimer’s Disease
More Young Adults Now Have Health Insurance
Funds Committed to Expand Community Health Centers
Reimbursement FAQs
Reimbursement FAQs
Industry News
Shocking: A "Newer" Hetastarch Product Is Nephrotoxic and Deadly in Severe Sepsis
Malaria Vaccine Close to Reality
Vaccine May Halt Autoimmune Disease
Brain Tumor Vaccine Shows Promise in Trials
Study Confirms Breast Cancer and Autoimmune Arthritis Link
Fundraising Effort in Progress for Treating Critical Care Patients
BRI and Novo Nordisk Collaborate on Autoimmune Disease Research
People and Places in the News
Osteoporosis Drug May Help Kill Flu Viruses
HHS Recognizes Facilities for Preventing HAIs
Flu Vaccine Coverage Well Below Healthy People 2020 Objectives
Gene Therapy May Reverse Hemophilia
New Possible Cause for Unexplained Miscarriages
Personalized Immune Mouse to Study Autoimmune Disease

BioFocus

Patient Profile
The Road to Remission
By Trudie Mitschang
Physician Profile
Crohn's Disease: A Physician's Perspective
By BSTQ Staff

BioSources

BioResearch
rIX-FP Protein Exhibits Prolonged Circulating Half-Life in Hemophilia B Patients
2010-2011 Trivalent Influenza Vaccine with All Three Vaccine Strains Was Moderately Effective
IVIG Discontinued Much Less Frequently than Methylprednisolone for CIDP